JP2024536863A5 - - Google Patents

Info

Publication number
JP2024536863A5
JP2024536863A5 JP2024518817A JP2024518817A JP2024536863A5 JP 2024536863 A5 JP2024536863 A5 JP 2024536863A5 JP 2024518817 A JP2024518817 A JP 2024518817A JP 2024518817 A JP2024518817 A JP 2024518817A JP 2024536863 A5 JP2024536863 A5 JP 2024536863A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
substituted
unsubstituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024518817A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024536863A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/077000 external-priority patent/WO2023049886A1/en
Publication of JP2024536863A publication Critical patent/JP2024536863A/ja
Publication of JP2024536863A5 publication Critical patent/JP2024536863A5/ja
Pending legal-status Critical Current

Links

JP2024518817A 2021-09-27 2022-09-26 イミダゾピリダジンil-17阻害剤化合物 Pending JP2024536863A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163248563P 2021-09-27 2021-09-27
US63/248,563 2021-09-27
US202163273407P 2021-10-29 2021-10-29
US63/273,407 2021-10-29
US202263371910P 2022-08-19 2022-08-19
US63/371,910 2022-08-19
PCT/US2022/077000 WO2023049886A1 (en) 2021-09-27 2022-09-26 Imidazopyridazine il-17 inhibitor compounds

Publications (2)

Publication Number Publication Date
JP2024536863A JP2024536863A (ja) 2024-10-08
JP2024536863A5 true JP2024536863A5 (cg-RX-API-DMAC7.html) 2025-09-19

Family

ID=83693127

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024518817A Pending JP2024536863A (ja) 2021-09-27 2022-09-26 イミダゾピリダジンil-17阻害剤化合物

Country Status (10)

Country Link
US (2) US12215111B2 (cg-RX-API-DMAC7.html)
EP (1) EP4408529A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024536863A (cg-RX-API-DMAC7.html)
KR (1) KR20240082371A (cg-RX-API-DMAC7.html)
AU (1) AU2022348938A1 (cg-RX-API-DMAC7.html)
CA (1) CA3233625A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024003770A (cg-RX-API-DMAC7.html)
TW (1) TW202329933A (cg-RX-API-DMAC7.html)
UY (1) UY39957A (cg-RX-API-DMAC7.html)
WO (1) WO2023049886A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022348938A1 (en) 2021-09-27 2024-05-16 Janssen Pharmaceutica Nv Imidazopyridazine il-17 inhibitor compounds
TW202430165A (zh) 2022-12-02 2024-08-01 丹麥商理奧藥品公司 Il-17之小分子調節劑
WO2024138286A1 (en) * 2022-12-26 2024-07-04 Usynova Pharmaceuticals, Ltd. Il-17a modulators
AU2024213283A1 (en) * 2023-01-30 2025-08-14 Dice Alpha, Inc. Benzimidazole and aza-benzimidazole based il-17a modulators and uses thereof
EP4688156A1 (en) * 2023-03-28 2026-02-11 Janssen Pharmaceutica NV Lactam-containing imidazopyridazine il-17 inhibitor compounds
WO2025202922A1 (en) * 2024-03-27 2025-10-02 Janssen Pharmaceutica Nv Imidazopyridazine il-17 inhibitor compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111601799B (zh) * 2018-01-15 2023-06-09 Ucb生物制药有限责任公司 作为Il-17调节剂的稠合咪唑衍生物
TWI752400B (zh) * 2019-01-07 2022-01-11 美商美國禮來大藥廠 Il-17a抑制劑
GB201909190D0 (en) 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
CN112341450B (zh) * 2019-08-09 2022-05-17 成都先导药物开发股份有限公司 一种免疫调节剂
WO2021098844A1 (zh) * 2019-11-20 2021-05-27 成都先导药物开发股份有限公司 一种免疫调节剂
WO2021170627A1 (en) * 2020-02-25 2021-09-02 UCB Biopharma SRL Difluorocyclohexyl derivatives as il-17 modulators
JP7664947B2 (ja) 2020-04-30 2025-04-18 ヤンセン ファーマシューティカ エヌ.ベー. Il-17の調節因子としてのイミダゾリダジン
WO2023025783A1 (en) 2021-08-23 2023-03-02 Leo Pharma A/S Small molecule modulators of il-17
AU2022348938A1 (en) 2021-09-27 2024-05-16 Janssen Pharmaceutica Nv Imidazopyridazine il-17 inhibitor compounds
CN116143777A (zh) 2021-11-04 2023-05-23 四川海思科制药有限公司 一种可抑制il-17a的杂环化合物及其用途
WO2023078319A1 (zh) 2021-11-04 2023-05-11 海思科医药集团股份有限公司 一种可抑制il-17a的杂环化合物及其用途

Similar Documents

Publication Publication Date Title
JP2024536869A5 (cg-RX-API-DMAC7.html)
JP2023524018A5 (cg-RX-API-DMAC7.html)
JP2024100974A5 (cg-RX-API-DMAC7.html)
CN115667239A (zh) 取代吡嗪类化合物,包含其的药物组合物及其用途
JP3971704B2 (ja) 一酸化窒素合成酵素阻害物質であるリン酸塩
JP2024536868A5 (cg-RX-API-DMAC7.html)
NL1028087C2 (nl) Sulfonamiderivaten voor de behandeling van ziekten.
JP2022519323A5 (cg-RX-API-DMAC7.html)
JP2023523770A5 (cg-RX-API-DMAC7.html)
JP2018535967A5 (cg-RX-API-DMAC7.html)
JP2009524691A5 (cg-RX-API-DMAC7.html)
JP2021535174A5 (cg-RX-API-DMAC7.html)
JP2020502047A5 (cg-RX-API-DMAC7.html)
RU2003105805A (ru) Производные 4-фенилпиридина в качестве антагонистов рецепторов нейрокинина-1
EP2044023A1 (en) Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors
JP2024536862A5 (cg-RX-API-DMAC7.html)
JP2019535761A5 (cg-RX-API-DMAC7.html)
IL311751A (en) IL-17 imidazopyridazine inhibitory compounds
JP2022536160A5 (cg-RX-API-DMAC7.html)
JP2024009811A5 (cg-RX-API-DMAC7.html)
JP2010534669A5 (cg-RX-API-DMAC7.html)
JP2025515833A5 (cg-RX-API-DMAC7.html)
JP2025508971A5 (cg-RX-API-DMAC7.html)
JP2008509896A (ja) 保護化アミノチアゾールのフッ素化方法
JP5468543B2 (ja) アセトアミド立体異性体